Pharmaceutical compliance support in the United States
Regole locali, collegate al vostro modello globale.
Eunomia helps pharmaceutical and biotech teams plan US compliance operations, connecting federal and state requirements with review, engagement, monitoring and reporting workflows.
For international pharma teams preparing US commercial activity, emerging biotechs building compliance processes and compliance leaders coordinating multiple states, products and third parties.
La sfida pratica: United States
US requirements span federal law, FDA rules, programme integrity, transparency reporting, industry commitments and state laws. A national SOP may miss state-specific reporting, marketing-code or HCP interaction requirements.
Dai requisiti all’azione
Come può aiutarvi Eunomia
We can map planned activities to applicable requirements, identify state-specific questions for legal review and translate agreed controls into SOPs, approval routes and monitoring. Support can include promotional review coordination, HCP engagement and payment workflows, reporting checks, training and automation. Eunomia identifies Karen Glade as its Global Compliance Business Partner for the United States and Canada; confirm scope and specialist support before engagement.
Compliance farmaceutica: United States: ambito di supporto
01
Interpretazione dei codici locali e gestione delle richieste
02
Revisione delle interazioni con operatori sanitari e associazioni di pazienti
03
Requisiti locali di trasparenza e disclosure
04
Revisione di materiali promozionali e non promozionali
05
Valutazione di compliance per l’ingresso nel mercato
06
Valutazione dei requisiti di competenza e di lingua
Cosa ottenete
Requisiti applicabili (United States) integrati nei vostri processi globali
Responsabilità chiare per revisione ed escalation
Supporto locale senza costi fissi superflui
Le regole: United States
Cosa determina la compliance: United States…
Una breve guida ai principali quadri normativi e di autoregolamentazione. Ogni sintesi rimanda alla relativa fonte ufficiale qui sotto.
FDA prescription drug promotion
FDA rules require advertising to be truthful and non-misleading, with risk information in fair balance with benefit claims. Claims must be consistent with approved labeling and supported by appropriate evidence. Build review, reference checks, version control and applicable submissions into the workflow.
Consumer health claims
FTC guidance requires health-related advertising claims to be truthful, not misleading and adequately substantiated before dissemination. Review campaign net impression, including digital content, testimonials and implied claims, and retain supporting evidence.
Federal HCP arrangements
The federal Anti-Kickback Statute prohibits knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or reward referrals involving items or services payable by a federal healthcare programme. Assess arrangements on their facts; written terms, legitimate need, appropriate compensation and evidence of services are useful controls. Obtain legal advice where required.
Open Payments
Applicable manufacturers and group purchasing organisations report specified payments to covered recipients and certain physician ownership interests through CMS Open Payments. Applicability depends on statutory definitions. Build recipient validation, reconciliation, correction, attestation and records into the annual process; CMS thresholds change each year.
Industry codes and state requirements
The PhRMA Code is an industry commitment for companies that adopt it, not a federal statute. States may add conduct, registration, training, audit or disclosure obligations. Massachusetts, for example, requires covered manufacturers to register, follow its marketing code, train relevant staff, conduct annual audits and submit reports. Maintain a state-by-state assessment.
Questa panoramica ha finalità esclusivamente informative e non costituisce consulenza legale. Ambito e applicazione vanno verificati in relazione all’organizzazione, al mercato, all’attività e alla controparte interessati. Fonti verificate a settembre 2026.
Domande e risposte
Compliance farmaceutica: United States: domande frequenti
Does FDA pre-approve every US promotional material?
No. FDA says pre-approval is generally not required, subject to limited exceptions and specific requirements. Companies remain responsible for compliant content and applicable submissions.
Does one federal process cover every state?
No. States may impose additional conduct, registration, training, audit or disclosure rules. Assess states where the company, agents and activities operate.
Does Eunomia have a US office or formal regulatory representative?
This guide does not claim a US office or formal regulatory appointment. Eunomia identifies Karen Glade as its Global Compliance Business Partner for the United States and Canada. Contact us to confirm expertise and delivery arrangements.
Raccontateci cosa avete sulla scrivania.
Vi ascolteremo, faremo qualche domanda e consiglieremo l’ambito più adatto, senza impegno né pressioni.